Navigation Links
Commonly used 3-drug regimen for idiopathic pulmonary fibrosis found harmful
Date:10/21/2011

recommendation of the Data and Safety Monitoring Board (DSMB) an independent advisory group of experts in lung disease, biostatistics, medical ethics, and clinical trial design. The DSMB has been monitoring the study since it began.

This study, called PANTHER-IPF (Prednisone, Azathioprine, and N-acetylcysteine: A Study that Evaluates Response in Idiopathic Pulmonary Fibrosis) was designed and conducted by the Idiopathic Pulmonary Fibrosis Clinical Research Network, funded by the NHLBI. The PANTHER-IPF study was designed to evaluate whether this commonly used triple-therapy regimen could slow disease progression and improve lung function in people with moderate IPF.

PANTHER-IPF was the first study in IPF comparing the effectiveness of this combined treatment to a placebo for all three drugs. Each participant had a one in three chance of being randomized to receive the triple drug regimen, NAC alone, or placebo for a period of up to 60 weeks.

"We will continue to analyze the data to try to understand why this particular combination may be detrimental in people with IPF," said Fernando Martinez, M.D., professor of medicine, University of Michigan, Ann Arbor and co-chair of the PANTHER-IPF study. "The results are not explained by any differences between the two groups before the treatments started."

IPF is a progressive and currently incurable disease characterized by the buildup of fibrous scar tissue within the lungs. This accumulation of scar tissue leads to breathing difficulties, coughing, chest pain, and fatigue. Approximately 200,000 people in the United States have IPF. The cause or causes of IPF remain unknown; as a result treatment options remain limited. PANTHER-IPF began enrollment in October 2009.

The study had enrolled 238 of a planned 390 participants prior to the stop announcement. Participants ranged from 48 to 85 years of age, with an average age of 68. The placebo and NAC arms will continue enrollin
'/>"/>

Contact: NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung and Blood Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Commonly used supplement may improve recovery from spinal cord injuries
2. Commonly used defibrillators raise risk of problems
3. Study shows PRP, commonly used technique to improve healing, doesnt work in rotator cuff surgery
4. Hepatitis C patients likely to falter in adherence to treatment regimen over time, Penn study shows
5. Integrating medication regimens into daily routines can improve adherence
6. Best post-transplant drug regimen identified for patients with new kidneys
7. Asian lung cancer patient survival exceeds Caucasians on multiple regimens
8. Early success of anti-HIV preventive oral drug regimen is promising, but questions remain
9. 6-month drug regimen cuts HIV risk for breastfeeding infants, NIH study finds
10. Bleeding Risk With Plavix-Aspirin Regimen May Be Serious
11. Studies Tout Alternative HIV Regimens for Women, Babies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 Texting has become a common and ... some physicians text as a way to communicate with patients ... are doing so to assure medical records are updated after ... risk! When providers transmit protected health information (PHI), or ... the risk of violating the Health Insurance Portability and Accountability ...
(Date:5/5/2015)... 2015 Lauren Blanda, general merchandising manager ... Sports , was named one of the top young ... by the SportsOneSource in its annual ... is one of 40 executives under the age of ... recognized for exceptional achievement in the industry. A ...
(Date:5/4/2015)... 05, 2015 The National ... Irene Taylor , Volunteer Executive Director of National ... inductee into its VIP Woman of the Year ... for leadership in business. NAPW is the nation's ... more than 700,000 members and over 200 Local ...
(Date:5/4/2015)... Garden City, NY (PRWEB) May 05, 2015 ... honors Gloria M. Betancourt as a ... Year Circle. She is recognized with this prestigious distinction ... networking organization exclusively for professional women, boasting more than ... "I'm pleased to present Gloria with this important honor," ...
(Date:5/4/2015)... UK (PRWEB) May 04, 2015 During ... witness a 7.7% CAGR. Currently, the European and APAC ... world, while the North American probiotic market lags behind ... local population. , The North American probiotic market ... over 58%), followed by Canada and Mexico. The North ...
Breaking Medicine News(10 mins):Health News:HIPAA Compliant Texting Service from MedXcom now available for Policyholders 2Health News:Sporting Goods Trade Group Names City Sports’ Lauren Blanda to Its Annual “40 Under 40” List 2Health News:Sporting Goods Trade Group Names City Sports’ Lauren Blanda to Its Annual “40 Under 40” List 3Health News:National Association of Professional Women Inducts Irene Taylor into its 2015-2016 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Gloria Betancourt, Receptionist at Consulate Health Care, into its 2015-2016 VIP Woman of the Year Circle 2Health News:North America Probiotic Market to Increase by 2019, Announces MicroMarketMonitor in Its New Research Report Recently Published at MarketPublishers.com 2
... Center for Obesity are the first and only in Southern California to ... complication, and the Hispanic community is benefiting. , ... Los Angeles, CA ... for Obesity are the first and only in Southern California to provide ...
... Aronowitz, has respected experience in plastic surgery procedures for post bariatric ... patients, health and wellness. Dr. Aronowitz and staff have an ... ... Los Angeles, CA (PRWEB) August 29, 2008 -- Bariatric surgery ...
... person with dementia led to daytime tiredness, symptoms of ... adults who live with and provide direct care during ... sleep than other older adults, U.S. researchers say. ... ages 60 to 89. Caregivers slept about 33 minutes ...
... 138% versus Q2 2007 - Nine new ... /PRNewswire-FirstCall/ - CRH Medical Corporation,(CRM:TSX-V) announced today unaudited results for ... are in US dollars). Revenue for the three,months ended June ... same period in 2007. Revenue for the six months ended ...
... lead clinical efforts of the Maryland Medicaid contract, ... national medical,management firm, appointed Lenaye Lawyer, MD, FACOG, ... oversee all clinical aspects of Medicaid,operations being performed ... Lawyer has practiced her entire medical career in ...
... based in the Northeast region with more hires,planned ... HARRISBURG, Pa., Aug. 28 The Pennsylvania,Patient Safety ... the,Northeast region to help healthcare facilities that report ... patient,safety for Pennsylvania citizens., "Last year in ...
Cached Medicine News:Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:Older Caregivers Prone to Worse Sleep Patterns 2Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
(Date:5/4/2015)... , May 4, 2015 Former NASA ... News online last week where he discussed Theradome™, the ... be FDA-cleared. The FOX segment shows firsthand how, via ... affordable hair loss solution that will not require surgery ... the mitochondria at the base of the hair follicle, ...
(Date:5/4/2015)... and TORONTO , May 4, ... (OTCQB:GNBT) today announced that it intends to dividend to ... upon completion of a definitive licensing agreement to license ... ( www.smoofi.com ) (OTCQB:SMFI). As announced on ... of intent in respect of the licensing of its ...
(Date:5/4/2015)... 4, 2015  Impax Laboratories, Inc. (NASDAQ: IPXL ... leadership roles, appointing  Donna M. Hughes, as Senior Vice ... as Senior Vice President, Chief Compliance Officer. Both Ms. ... and Chief Executive Officer, Fred Wilkinson . ... joined the Impax team," said Fred Wilkinson , ...
Breaking Medicine Technology:FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 4Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 5Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 3
... provides the foundation for improving understanding of N-myc,gene,s ... when,retinoblastoma forms, MEMPHIS, Tenn., Jan. 16 ... Children,s Research Hospital helps answer a,long-standing mystery about ... deeper understanding of how genes coordinate the complex ...
... ... in Phase I Studies -, RESEARCH TRIANGLE PARK, ... and commercializing innovative,treatments for diseases of the central nervous system, today ... its,lead candidate for the treatment of depression and anxiety. Tyrima is ...
Cached Medicine Technology:St. Jude Defines Eye Cancer Gene's Role in Retinal Development 2St. Jude Defines Eye Cancer Gene's Role in Retinal Development 3CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM) 2CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM) 3
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
The design of the new ChloraPrep swabstick applicator provides significant improvement in performance over traditional swabsticks....
... Swabsticks are packaged in easy open, single-use ... saturated with precisely the correct amount of ... the safest possible product for the patient. ... an excellent combination of ethyl alcohol and ...
... provides 5% povidone-iodine solution ... It delivers a microbicidal ... tender to touch. It ... indicated whenever effective microbicidal ...
Medicine Products: